Cutaneous sarcoidosis associated with cosmetic fillers
Cutaneous sarcoidosis associated with cosmetic fillers
复制标题
与化妆品填充剂相关的皮肤结节病
DOI:
--
复制
发表时间:
2009
影响因子:
9.2
通讯作者:
L. Izikson
中科院分区:
文献类型:
--
作者:
L. Izikson
Discussion Why and how melanocytes disappear to induce the vitiligo lesions is not fully understood. There are three major hypotheses for pathogenesis of vitiligo: (i) neural hypothesis suggests that neurochemical substance decreases melanin production and the melanocytes could be damaged by a toxin produced and released from the nerve endings; (ii) a complex biochemical imbalance and defective free-radical defence could affect production of melanin; (iii) autoimmune hypothesis. The most popular hypothesis is the autoimmune hypothesis. In literature, circulating antibodies to melanocytes was detected in vitiligo patients. Also, circulating melanocyte-specific cytotoxic T cells have been detected in high frequencies in the patients with vitiligo. The association of vitiligo and autoimmune disorders indirectly supports the idea of an autoimmune pathogenesis of the disease. Prolactin is made mainly in the anterior pituitary gland; however it is also produced in T lymphocytes, B lymphocytes, and human chorion. Prolactin is a growth factor for lymphocytes with the potential to stimulate immune responses at many levels and affect as a cytokine. Prolactin stimulates interferon regulatory factor-1 that is required for Th1 responses and can regulate Th1 cytokines such as interferon-c and interleukin-15. Elevated levels of prolactin have been found in patients with SLE, RA, psoriatic arthritis, multiple sclerosis, Reiter’s syndrome, primary Sjögren’s syndrome, psoriasis and uveitis. Our study is the first study that investigated prolactin levels in vitiligo patients. We could not found significant difference in prolactin levels in the patient and control groups. Also, no correlation was found between prolactin levels and age and sex of the patients, duration of the disease, family history and expansion of the vitiligo. Our results suggest that prolactin does not play a role in the pathogenesis of vitiligo.